ARLINGTON, Va. – In response to the Food and Drug Administration’s (FDA) proposed rule on prescription drug importation, Healthcare Distribution Alliance (HDA) president and CEO Chester “Chip” Davis, Jr. released the following statement: “As the vital link within the healthcare ecosystem, HDA’s pharmaceutical distributor members share FDA’s commitment to ensuring that Americans have access to
HARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) released the following statement regarding the Department of Health and Human Services’ (HHS) proposed rule permitting prescription drug importation: “As an industry that saves healthcare between $33 and $53 billion each year by ensuring the safety, reliability and efficiency of the supply chain, HDA and its pharmaceutical
ARLINGTON, Va. — In response to the release of the U.S. Department of Justice Office of the Inspector General’s Review of the Drug Enforcement Administration’s (DEA) Regulatory and Enforcement Efforts to Control the Diversion of Opioids, John Parker, senior vice president of communications with the Healthcare Distribution Alliance (HDA) released the following statement last week: “Today’s
ARLINGTON, Va. — In response to the release of the U.S. Department of Justice Office of the Inspector General’s Review of the Drug Enforcement Administration’s (DEA) Regulatory and Enforcement Efforts to Control the Diversion of Opioids, John Parker, senior vice president of communications with the Healthcare Distribution Alliance (HDA) released the following statement. “Today’s report by the
ORLANDO, Fla. — The Healthcare Distribution Alliance (HDA) honored pharmaceutical and consumer product manufacturers with the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA). The honorees were formally recognized during the DIANA and Nexus Awards dinner at the HDA 2019 Business and Leadership Conference in Orlando, Fla. This year marks the DIANA Awards’
STAMFORD, Conn. – Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to Novartis and its Sandoz division, in recognition of their outstanding commitment to increasing access to health care around the world. Americares senior vice president of global programs Dr. E. Anne Peterson presented the award
ARLINGTON, Va. — Healthcare Distribution Alliance (HDA) president and chief executive officer John Gray issued the following statement in response to the Drug Enforcement Administration’s (DEA) announcement of an enhanced data tool to support additional information sharing with pharmaceutical distributors and manufacturers: “The DEA has taken an important step to enhance data transparency and address a
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) announced today the election of Greg Drew, president of Value Drug Company, as chairman of HDA’s board of directors. Robert Mauch, executive vice president and group president at AmerisourceBergen Corporation, was elected vice chairman. The new leadership was announced at the HDA Annual Board and Membership Meeting. Drew,
ARLINGTON, Va. — Allied Against Opioid Abuse (AAOA), a national initiative to help prevent prescription opioid abuse and misuse through education, has created a pharmacy toolkit to equip pharmacists with resources to engage and educate patients about the safe use, storage and disposal of pain medicines. AAOA, along with its founding member, the Healthcare Distribution Alliance (HDA),
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) will convene pharmaceutical supply chain industry leaders at its Traceability Seminar, October 17 to 19 in Washington, D.C. The 2018 seminar will educate attendees about where the pharmaceutical supply chain is in relation to achieving full implementation of the Drug Supply Chain Security Act (DSCSA) in 2023; what to expect
ARLINGTON, Va. —Healthcare Distribution Alliance (HDA) president and chief executive officer John Gray released the following statement on the Department of Health and Human Services’ (HHS) recent directive to establish a Food and Drug Administration (FDA) work group to examine prescription drug importation policies: “HDA and the nation’s primary pharmaceutical distributors appreciate the Trump administration’s efforts
COLORADO SPRINGS, Colo. — The Healthcare Distribution Alliance (HDA) honored pharmaceutical and consumer product manufacturers with the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA). The awards were distributed at the HDA 2018 Business and Leadership Conference here. The DIANA Awards have been a symbol of excellence in the pharmaceutical supply chain since 1959.
STAMFORD, Conn. – Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to Mylan, in recognition of its outstanding commitment to increasing access to health care around the world. Mylan is among Americares most dedicated and longstanding supporters, providing pharmaceutical products for the organization’s health programs for people affected
